[2017] Why vaccine manufacturers are exempt from liability

In 1986 Congress passed the National Childhood Vaccine Injury Act (NCVIA), creating a no-fault compensation program to stabilize a vaccine market adversely affected by an increase in vaccine-related lawsuits and to facilitate compensation to claimants who found pursuing legitimate vaccine-inflicted injuries too difficult and cost prohibitive.

Why vaccine manufacturers are exempt from liability

Oklahoma AG declares medical boards can’t punish doctor for prescribing ivermectin

LifeSiteNews | February 16, 2022

OKLAHOMA CITY – Doctors in Oklahoma are well within their professional rights to prescribe ivermectin (IVM) and hydroxychloroquine (HCQ) to COVID-19 patients, state Attorney General John O’Connor affirmed, despite the drugs’ disfavored status within the federal health bureaucracy.

Oklahoma AG declares medical boards can’t punish doctor for prescribing ivermectin

Trump promises seniors $200 prescription drug gift certificates, but questions abound

Trump promises seniors $200 prescription drug gift certificates, but questions abound

The administration is getting its authority to ship the coupons from a Medicare demonstration program, a White House spokesman told STAT in a statement. The nearly $7 billion required to send the coupons, he said, would come from savings from Trump’s “most favored nations” drug pricing proposal. That regulation has also not yet been implemented — meaning the Trump administration is effectively pledging to spend $6.6 billion in savings that do not currently exist. The cards, he said, would be “actual discount cards for prescription drug copays.

Related:

Trump’s ‘most favored nation’ executive order on drug prices is a scam for seniors

Yet none of these reference pricing proposals show how they would directly reduce out-of-pocket costs for seniors at the pharmacy counter. For example, an Avalere study found that fewer than 1% of older adults in Medicare Part B would see a reduction in out-of-pocket costs as a result of the international pricing index model. In all likelihood, the prices of drugs in other countries will be more affected by the executive order than U.S. drug prices.